Seegene, Inc. (KOSDAQ:096530)
24,950
-250 (-0.99%)
Oct 10, 2025, 3:30 PM KST
Seegene Revenue
Seegene had revenue of 114.06B KRW in the quarter ending June 30, 2025, with 13.90% growth. This brings the company's revenue in the last twelve months to 454.22B, up 18.76% year-over-year. In the year 2024, Seegene had annual revenue of 414.25B with 12.76% growth.
Revenue (ttm)
454.22B
Revenue Growth
+18.76%
P/S Ratio
2.53
Revenue / Employee
2.10B
Employees
216
Market Cap
1,150.50B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 414.25B | 46.88B | 12.76% |
Dec 31, 2023 | 367.38B | -486.19B | -56.96% |
Dec 31, 2022 | 853.56B | -517.27B | -37.73% |
Dec 31, 2021 | 1,370.83B | 245.62B | 21.83% |
Dec 31, 2020 | 1,125.22B | 1,003.26B | 822.66% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
LigaChem Biosciences | 148.28B |